XTX Topco Ltd - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
XTX Topco Ltd ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$96,907
+10.1%
23,073
+57.3%
0.02%
-44.4%
Q2 2022$88,000–14,669–0.04%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders